Beyond Transcriptomes and Dissociated Cells: Spatial Proteomics for Mechanistic Neurobiology
Year: 2026
Type: review
Abstract: Single-cell transcriptomic studies have revealed remarkable molecular heterogeneity across neuronal and glial populations during development, aging, and disease. However, dissociation-based approaches disrupt tissue architecture, and RNA measures alone incompletely capture cellular function. These limitations are particularly relevant in neurodegenerative diseases, where pathology develops within cellular microenvironments and diseased cells progressively lose canonical cell-state identity markers. Spatial proteomic approaches are beginning to address this critical gap by enabling high-dimensional molecular profiling within the intact tissue, preserving the spatial relationships between vulnerable cells and their surrounding cellular environments across scales ranging from subcellular single-cell imaging to large-volume three-dimensional mapping. Here, we discuss emerging spatial proteomic technologies and their applications in aging and neurodegeneration, emphasizing how integration with complementary modalities, including transcriptomics, glycomics, three-dimensional genome architecture, and quantitative neuropathology, is providing new insight into disease biology. We further highlight how these approaches are beginning to accelerate therapeutic target validation, biomarker discovery, and treatment response monitoring. Realizing the full potential of spatial proteomics will require continued advances in cross-platform harmonization, analytical standardization, and computational methods capable of integrating increasingly complex, multimodal datasets.
Source: Journal of Neuroscience
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: spatial proteomics, neurodegeneration, brain aging, single-cell transcriptomics, tissue structure, cell microenvironment, 3D genome organization, glycomics, quantitative neuropathology, multimodal data integration, drug target validation, biomarker discovery, treatment response monitoring, cell state heterogeneity
Open Access status: hybrid
Funders: U.S. Department of Veterans Affairs, American Federation for Aging Research, Alzheimer's Drug Discovery Foundation, Cure Alzheimer's Fund, Coins for Alzheimer's Research Trust, Rainwater Charitable Foundation, Alzheimer's Research Trust, National Institutes of Health, National Institute on Aging, National Institute of Mental Health
Awards: G6665814017, High Resolution Profiling of Senescent Cells in ALS Brain and Spinal Cord, Cell type atlasing of whole human brains using HOLiS: an optimized pipeline for staining, clearing, imaging, and analysis, Deciphering the Glycan Code in Human Alzheimer's Disease Brain, Predoctoral and Postdoctoral Training Program in Aging and Dementia, University of Washington Alzheimer's Disease Research Center, Identification and Characterization of Senescent Cells in Molecular Subtypes of Alzheimer's Disease, A multimodal brain cell atlas and community resource of Alzheimer's disease and comorbid dementias.
OpenAlex ID: W7225858858
